NCT05057299View on ClinicalTrials.gov

Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Acute Myeloid Leukemia
Interventions
OTHER

retrospective data analysis

chart review, analysis and reporting outcomes

Trial Locations (1)

11941

King Hussein Cancer Center, Amman

All Listed Sponsors
lead

King Hussein Cancer Center

OTHER

NCT05057299 - Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes | Biotech Hunter | Biotech Hunter